Showing 1 - 6 results of 6 for search 'T Caravita di Toritto', query time: 0.03s Refine Results
  1. 1
    Immunotactoid glomerulopathy and chronic lymphocytic leukemia: The need for a multidisciplinary approach

    Immunotactoid glomerulopathy and chronic lymphocytic leukemia: The need for a multidisciplinary approach by Angela Rago, Laura Pettorini, Alessandro Andriani, Tommaso Caravita di Toritto

    Published 2023-02-01
    Get full text
    Article
  2. 2
    High dose chemotherapy and autologous stem cell transplantation in Multiple Myeloma patients over 70 years: “GIMEMA Working Group Lazio experience

    High dose chemotherapy and autologous stem cell transplantation in Multiple Myeloma patients over 70 years: “GIMEMA Working Group Lazio experience by A. Rago, O. Annibali, V. Tomarchio, A. Fiorini, F. Fazio, U. Coppetelli, L. De Rosa, E. Papa, M.P. Bianchi, G. Antolino, T. Caravita di Toritto

    Published 2020-09-01
    Get full text
    Article
  3. 3
    P23: RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS. A MULTICENTER RETROSPECTIVE ANALYSIS OF ELIGIBILITY CRITERIA FOR CAR-T CELL THERAPY.

    P23: RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS. A MULTICENTER RETROSPECTIVE ANALYSIS OF ELIGIBILITY CRITERIA FOR CAR-T CELL THERAPY. by F Fazio, A Di Rocco, T Za, V Tomarchio, A Rago, A Piciocchi, T Caravita di Toritto, O Annibali, V De Stefano, R Foà, M Martelli, MT Petrucci

    Published 2022-04-01
    Get full text
    Article
  4. 4
    PB2024: PREVALENCE OF TYPE 1 GAUCHER DISEASE IN PATIENTS WITH MULTIPLE MYELOMA: FIRST INTERIM ANALYSIS OF A PROSPECTIVE, MULTICENTER, OBSERVATIONAL STUDY

    PB2024: PREVALENCE OF TYPE 1 GAUCHER DISEASE IN PATIENTS WITH MULTIPLE MYELOMA: FIRST INTERIM ANALYSIS OF A PROSPECTIVE, MULTICENTER, OBSERVATIONAL STUDY by M. Offidani, C. Zizzo, S. Rupoli, I. Federici, A. Bossi, S. Morè, V. M. Manieri, M. T. Petrucci, T. Caravita di Toritto, M. Brunori, A. Gozzetti, A. Tordi, F. Fazio, C. Lisi, E. Morsia, L. Corvatta, A. Olivieri, G. Duro

    Published 2022-06-01
    Get full text
    Article
  5. 5
    Daratumumab combined with dexamethasone and lenalidomide or bortezomib in relapsed/refractory multiple myeloma (RRMM) patients: Report from the multiple myeloma GIMEMA Lazio group

    Daratumumab combined with dexamethasone and lenalidomide or bortezomib in relapsed/refractory multiple myeloma (RRMM) patients: Report from the multiple myeloma GIMEMA Lazio group by Francesca Fazio, Luca Franceschini, Valeria Tomarchio, Angela Rago, Maria Grazia Garzia, Luca Cupelli, Velia Bongarzoni, Alessandro Andriani, Svitlana Gumenyuk, Agostino Tafuri, Agostina Siniscalchi, Alfonso Piciocchi, Paolo De Fabritiis, Luca De Rosa, Tommaso Caravita di Toritto, Ombretta Annibali, Maria Cantonetti, Maria Teresa Petrucci

    Published 2022-02-01
    Get full text
    Article
  6. 6
    Consensus for Flow Cytometry Clinical Report on Multiple Myeloma: A Multicenter Harmonization Process Merging Laboratory Experience and Clinical Needs

    Consensus for Flow Cytometry Clinical Report on Multiple Myeloma: A Multicenter Harmonization Process Merging Laboratory Experience and Clinical Needs by Iole Cordone, Rachele Amodeo, Silvia Bellesi, Fiorella Bottan, Francesco Buccisano, Maria Stefania De Propris, Serena Masi, Valentina Panichi, Maria Cristina Scerpa, Ombretta Annibali, Velia Bongarzoni, Tommaso Caravita di Toritto, Ugo Coppetelli, Luca Cupelli, Paolo de Fabritiis, Luca Franceschini, Mariagrazia Garzia, Alessia Fiorini, Giacinto Laverde, Andrea Mengarelli, Tommaso Za, Maria Teresa Petrucci

    Published 2023-03-01
    Get full text
    Article

Search Tools: